NCCN and Vietnam’s K Hospital Expand Cancer Care Collaboration with Breast and Ovarian Cancer Guidelines

Event summary

  • NCCN and K Hospital published adapted guidelines for breast and ovarian cancer treatment in Vietnam, adding to existing lung and liver cancer guidelines.
  • The guidelines are tailored to Vietnam’s healthcare system, regulatory environment, and available technologies.
  • Breast cancer is the most common cancer among Vietnamese women, accounting for ~14% of new cancer cases in 2022.
  • The collaboration includes a specialized algorithm for managing ovarian cancer during pregnancy.
  • NCCN and K Hospital first partnered in 2023, with plans to expand to colorectal, stomach, and other cancer guidelines.

The big picture

This collaboration aligns with a broader trend of global standardization in cancer care, where U.S.-based oncology leaders adapt their expertise to regional needs. The move also reflects Vietnam’s growing role in Southeast Asia’s healthcare landscape, as the country seeks to align its treatment protocols with international standards. With nearly 100 global adaptations of NCCN guidelines already in place, this partnership could further solidify NCCN’s position as a leader in cross-border oncology collaboration.

What we're watching

Execution Risk
Whether NCCN and K Hospital can sustain the pace of guideline adaptations while maintaining quality and local relevance.
Regional Expansion
How this collaboration could serve as a model for similar partnerships in other emerging markets.
Knowledge Exchange
The extent to which insights from Vietnam’s healthcare system improve NCCN’s global guidelines.

Related topics

Oncology